Tirzepatide tracker
for iPhone.
Tirzepatide on a weekly schedule looks simple on paper — one shot, every seven days — and quickly stops being simple in practice. Doses escalate. The reconstitution math depends on the vial you got. Side effects ride the dose-up weeks. Peptide Protocol is built for exactly this: a calm iPhone tracker that knows your escalation, draws the math, surfaces the side-effect pattern, and never lets you guess what week you're on.
Download Peptide Protocol — FreeTirzepatide at a glance
Quick reference for the protocol-builder. For full primary-literature sourcing and clinical context, follow the cross-link to our sister site.
| Class | GLP-1 / GIP dual agonist (incretin mimetic) |
|---|---|
| Brand names | Mounjaro (T2D), Zepbound (chronic weight management) — same molecule, both manufactured by Eli Lilly |
| Plasma half-life | ~5 days |
| Typical cadence | Once weekly, subcutaneous |
| Typical dose range | 2.5 mg → 5 mg → 7.5 mg → 10 mg → 12.5 mg → 15 mg, escalating every 4 weeks per FDA label |
| Common reconstitution | 10 mg vial + 2.0 mL bacteriostatic water → 5 mg/mL → 0.05 mL = 2.5 mg dose |
| Insulin syringe | U-100 most common (5 units = 0.05 mL = 2.5 mg at 5 mg/mL) |
| Common stack pairings | Cagrilintide ("CagriSema" pattern) for additive appetite suppression |
| Common side-effect pattern | Nausea and GI discomfort during dose-up weeks; usually subsides within 5–7 days |
For full Tirzepatide dosing guidance, prescribing information references, and side-effect literature, see the Tirzepatide guide on peptide-calc.app.
Built around Tirzepatide protocols
Three things the app does that a spreadsheet, the manufacturer pen, or a generic reminders app won't.
Knows your escalation week
Add the 2.5 → 15 mg ladder once. The app increments your target dose automatically every 4 weeks (or whatever cadence you set) and the calculator output stays in sync — no edits, no guesswork on dose-up day.
Reconstitution math, vial-aware
Pick the vial mass (5/10/15 mg) and how much BAC water you added. The app shows the exact U-100 / U-50 / U-30 unit count to draw for your current dose. When the dose changes, the units update — your hand doesn't have to re-do the math.
Side-effect log next to the dose log
The daily check-in captures appetite, energy, sleep, weight, and free-text notes. The weekly report puts the 7-day symptom pattern next to the dose timeline so you can see — and show your clinician — exactly how each escalation step landed.
What it looks like
Tirzepatide tracking — common questions
Does Peptide Protocol have a Tirzepatide preset?
Yes. The reconstitution calculator ships with Tirzepatide presets at common vial strengths (5 mg, 10 mg, 15 mg). Pick the vial size and BAC water volume you used, set your target dose, and the app shows the exact units to draw on a U-100, U-50, or U-30 insulin syringe.
How do I track a Tirzepatide escalation schedule?
When you build the protocol, set the starting dose (typically 2.5 mg) and add scheduled step-ups every 4 weeks (5 mg → 7.5 mg → 10 mg → 12.5 mg → 15 mg). The app increments the target dose automatically on the scheduled date and updates the calculator output, so the next draw is always correct without manual edits.
Can the app track Tirzepatide GI side effects between doses?
Yes. The daily check-in captures appetite, energy, sleep, and weight on a 0–10 scale, plus free-text notes for nausea, GI discomfort, or other effects. The weekly report aggregates the 7-day pattern next to your dose log so you can correlate symptom days with each escalation step.
Related peptide trackers
Track your Tirzepatide on your iPhone.
Free on the App Store. Builds your first protocol in under five minutes. No account required.
Download on the App StoreNot medical advice. Peptide Protocol is a personal tracking tool — it does not diagnose, prescribe, or replace a clinician. Tirzepatide is a prescription medication in most jurisdictions and is restricted to authorized providers. Always consult a licensed healthcare professional before starting, modifying, or stopping any compound. The data on this page is informational and based on the FDA prescribing information for Mounjaro / Zepbound (Eli Lilly) — see the full Tirzepatide reference for primary sources.